MAIA Biotechnology, Inc.

MAIA · NYSE · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.1B · 13 employees
150
SEC Filings
$1.1
Close 2026-11-02
13
Employees

Business Summary

MAIA Biotechnology, Inc. is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. Its lead asset, ateganosine (THIO, 6-thio-dG), is an investigational dual mechanism drug candidate targeting telomeres and inducing immunogenicity. Ateganosine is being evaluated primarily in Non-Small Cell Lung Cancer (NSCLC) in Phase 2 (THIO-101) and Phase 3 (THIO-104) trials, with planned Phase 2 trials in hepatocellular carcinoma, colorectal cancer, and small cell lung cancer.

Latest Stock Quote

MAIA 2026-11-02 $1.1 O:$1.11 H:$1.14 L:$1.09 Vol:0.2M VWAP:$1.1137
origin leaf: null

Next Earnings

expected 2027-01-05

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-232025-12-310001493152-26-012088EDGAR113K words
2025-03-212024-12-310000950170-25-043190EDGAR97K words
2024-03-212023-12-310000950170-24-034764EDGAR90K words
2023-03-242022-12-310000950170-23-009766EDGAR91K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-092026-09-300001493152-26-050757EDGAR26K words
2026-08-102026-06-300001493152-26-036764EDGAR24K words
2025-11-072025-09-300001493152-25-021272EDGAR32K words
2025-08-112025-06-300001641172-25-022899EDGAR26K words
2025-05-092025-03-310000950170-25-068005EDGAR21K words
2024-11-122024-09-300000950170-24-125474EDGAR25K words
2024-08-092024-06-300000950170-24-094747EDGAR23K words
2024-05-142024-03-310000950170-24-059550EDGAR21K words
2023-11-072023-09-300000950170-23-059778EDGAR21K words
2023-08-082023-06-300000950170-23-039399EDGAR19K words
2023-05-082023-03-310000950170-23-018480EDGAR17K words
2022-11-092022-09-300000950170-22-023956EDGAR23K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-10-060001493152-26-045865EDGAR0K words
2026-04-020001493152-26-014924EDGAR1K words
2026-03-310001493152-26-013879EDGAR1K words
2026-03-270001493152-26-013088EDGAR1K words
2026-03-040001493152-26-008897EDGAR1K words
2026-02-240001493152-26-007831EDGAR1K words
2026-01-200001493152-26-002883EDGAR1K words
2026-01-130001493152-26-002085EDGAR0K words
2025-12-170001493152-25-028041EDGAR1K words
2025-12-110001493152-25-027244EDGAR1K words

150 total filings indexed. 124 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

non-small-cell-lung-cancer-(nsclc) hepatocellular-carcinoma-(hcc) colorectal-cancer-(crc) small-cell-lung-cancer-(sclc) oncology-/-cancer-immunotherapy recist-1.1-(response-evaluation-criteria-in-solid-tumors) ind-(investigational-new-drug)-application-process pct-(patent-cooperation-treaty)-patent-application-process

Company Identity

CIK0001878313
TickerMAIA
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE
HeadquartersChicago, Illinois
Websitehttps://www.maiabiotech.com
Listed2022-07-28

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: af6b02b0d2bd4b327af7ac3ed09bc898b5e2cdace08717959d23439bfa279e1f
parent: 9cb66da27fa2244d4d7437460272bf5a756d1ea1758b549ca87e264e09834f3a
content hash: 75156d9eb6b9256e26f7ad5c4bff0b44c0d74e9d6b2ac0a864df7cf2a5442784
signed: 2026-11-16T19:03:24.558Z
sources: 16 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up MAIA using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on MAIA, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/MAIA (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.